v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities    
Net (loss) income $ (2,568,899) $ 876,264
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Amortization of debt discount and debt issuance cost 951,942 406,841
Depreciation and amortization 33,333 33,333
Stock based compensation 116,307
Foreign currency transaction loss (gain) 2,684 (3,137)
Remeasurement loss (gain) on translation of foreign subsidiary 3,718 (1,412)
Changes in operating assets and liabilities:    
Accounts receivable 1,935,483 940,519
Other receivables 144,637
Loan receivable, related party (833)
Inventory 355,895 (629,935)
Prepaid expenses (410,657) (114,787)
Prepaid expense, related party (541,467) (195,913)
Income taxes payable (2,297) (165,413)
Contract liabilities (1,526) (24,216)
Accounts payable and accrued liabilities (1,915,323) (2,218,041)
Accounts payable, related party (3,871) 129,312
Net cash used in operating activities (2,044,678) (822,781)
Cash Flows from Investing Activities
Cash Flows from Financing Activities    
Advances from related party 135,000
Repayment of notes payable, related party (100,000)  
Proceeds from notes payable 2,660,000 1,496,250
Payment of loan financing fees (55,000)
Repayment of notes payable (2,812,600) (1,316,572)
Net cash (used in) provided by financing activities (307,600) 314,678
Effect of exchange rate on cash, cash equivalents and restricted cash 22,080 (1,935)
Net decrease in cash, cash equivalents and restricted cash (2,330,198) (510,038)
Cash and restricted cash, beginning of year 2,722,313 787,920
Cash and restricted cash, end of period 392,115 277,882
Cash paid during the period for:    
Interest 392,846 573,529
Income taxes
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Issuance of common stock for accounts receivable advance financing 117,648
Loan financing fees, accrued 110,000
Capitalized interest on senior debt 400,033
Common stock to be issued for accounts receivable advance financing $ 153,400